Literature DB >> 26688995

Effect of Revascularization on Headache Associated with Moyamoya Disease in Pediatric Patients.

Manoj Bohara, Sei Sugata, Yosuke Nishimuta, Prasanna Karki, Tetsuya Nagayama, Shigeyuki Sakamoto, Hiroshi Tokimura, Kazunori Arita.   

Abstract

Episodic headache is common in childhood moyamoya disease (MMD). The onset, mechanism, cause of headache and the effect of revascularization surgery on headache are not yet clear. We studied 10 cases of children (7 boys and 3 girls) younger than 18 years who underwent revascularization for MMD between 2009 and 2013. We evaluated frequency of headache and cerebral blood flow changes by single photon emission computed tomography brain imaging with [I123]-labeled iofetamine (IMP-SPECT) before and after surgery. Patients' ages ranged from 0 to 15 years at onset and 2 to 17 years at the time of surgery, mean age being 6.7 and 8.0 years respectively. 9 of 10 patients presented with ischemic symptoms and 8 had headache. 5 patients underwent indirect bypass and 5 underwent combined direct and indirect bypass. Cerebral blood flow improvement was obtained in 14 of the 15 cerebral hemispheres revascularized. The mean follow-up duration was 32.9 months. All the patients had good outcomes with improvement of ischemic neurological deficits. Headache improved in 7 (87.5%) of 8 patients. Headache in pediatric moyamoya disease is associated with change in cerebral hemodynamics. Revascularization including combined direct bypass and indirect techniques may be required to reduce headache in patients with MMD.

Entities:  

Mesh:

Year:  2015        PMID: 26688995

Source DB:  PubMed          Journal:  Hiroshima J Med Sci        ISSN: 0018-2052


  3 in total

1.  Aspirin use and platelet aggregation in ischemic onset-type pediatric moyamoya patients with intractable headaches (moya-ache).

Authors:  Yasuo Aihara; Shinobu Kashiwase; Kentaro Chiba; Koji Yamaguchi; Yoshikazu Okada; Toshimi Kimura; Takakazu Kawamata
Journal:  Childs Nerv Syst       Date:  2021-01-06       Impact factor: 1.475

2.  Clinical Characteristics and Long-Term Outcome of Headaches Associated With Moyamoya Disease in the Chinese Population-A Cohort Study.

Authors:  Bin Gao; Kaijiang Kang; Jia Zhang; Dong Zhang; Xingquan Zhao
Journal:  Front Neurol       Date:  2020-11-26       Impact factor: 4.003

3.  Assessment of Single-Barrel Superficial Temporal Artery-Middle Cerebral Artery Bypass in Treatment for Adult Patients with Ischemic-Type Moyamoya Disease.

Authors:  Xiaoyang Tao; Yin Liu; Jun Chen; Li Xu; Zhijie Zhou; Haiyan Lei; Yiming Yin
Journal:  Med Sci Monit       Date:  2018-10-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.